JANICE HUR
Following drug development milestones, Arvinas looks to make headway against breast cancer and brain diseases

The New Haven-based biopharmaceutical company and Yale spinoff hopes to use a unique protein-targeting technology in two promising drugs to stave off breast cancer and neurodegenerative diseases like Parkinson’s.

March 28, 2024

NANCY CHEN & JANICE HUR
Yale study finds that small molecule can increase white blood cell counts

The researchers discovered that the A485 molecule, known as “prohiberin,” helped mice fight against infection.

February 15, 2024

JANICE HUR
School of Medicine launches new online medical software and AI certificate program

Faculty hope that Yale Online's new online program will help professionals navigate an evolving landscape of technology in the medical field

December 11, 2023